Analysis of the relationship between phenotypes and genotypes in 60 Chinese patients with propionic acidemia: a fourteen-year experience at a tertiary hospital
单位:[1]Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China.[2]Department of Clinical Laboratory, China-Japan Friendship Hospital, Beijing, 100029, China.[3]Department of Endocrinology and Genetic, Beijing Children's Hospital, Capital Medical University, Beijing, 100045, China.首都医科大学附属北京儿童医院[4]Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.[5]Department of Endocrinology and Genetic, Henan Children's Hospital, Zhengzhou, 450053, China.[6]Translational Medicine Center, Chinese PLA General Hospital, Beijing, 100853, China.[7]School of Life Sciences, Central South University, Changsha 410000, China.
Background Propionic acidemia is a severe inherited metabolic disorder, caused by the deficiency of propionyl-CoA carboxylase which encoded by the PCCA and PCCB genes. The aim of the study was to investigate the clinical features and outcomes, molecular epidemiology and phenotype-genotype relationship in Chinese population. Methods We conducted a retrospective study of 60 Chinese patients diagnosed at Peking University First Hospital from 2007 to 2020. Their clinical and laboratory data were reviewed. The next-generation sequencing was conducted on blood samples from 58 patients. Results Only 5 (8.3%) patients were identified by newborn screening. In the rest 55 patients, 25 had early-onset (<= 3 months) disease and 30 had late-onset (> 3 months) disease. Neurological abnormalities were the most frequent complications. Five cases detected by newborn screening had basically normal development. Nine (15%) cases died in our cohort. 24 patients (41.4%) harbored PCCA variants, and 34 (58.6%) harbored PCCB variants. 30 (11 reported and 19 novel) variants in PCCA and 28 (18 reported and 10 novel) variants in PCCB mere identified. c.2002G>A and c.937C>T in PCCA, and c.838dupC in PCCB were the most common variants in this cohort, with the frequency of 13.9% (6/44 alleles), 13.9% (6/44 alleles) and 12.5% (8/64 alleles), respectively. There was no difference in clinical features and outcomes between patients with PCCA and PCCB variants. Certain variants with high frequencies and homozygotes may be associated with early-onset or late-onset propionic acidemia. Conclusions Although the genotype-phenotype correlation is still unclear, certain variants seemed to be related to early-onset or late-onset propionic acidemia. Our study further delineated the complex clinical manifestations of propionic acidemia and expanded the spectrum of gene variants associated with propionic acidemia.
基金:
National Key Research and Development Program of China [2019YFC1005100, 2017YFC1001700]; Key Clinical Specialty Project of Beijing
语种:
外文
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|2 区医学
小类|3 区遗传学3 区医学:研究与实验
最新[2025]版:
大类|2 区医学
小类|2 区遗传学2 区医学:研究与实验
JCR分区:
出版当年[2020]版:
Q2GENETICS & HEREDITYQ2MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q2GENETICS & HEREDITYQ2MEDICINE, RESEARCH & EXPERIMENTAL
第一作者单位:[1]Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China.[2]Department of Clinical Laboratory, China-Japan Friendship Hospital, Beijing, 100029, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Liu Yi,Chen Zhehui,Dong Hui,et al.Analysis of the relationship between phenotypes and genotypes in 60 Chinese patients with propionic acidemia: a fourteen-year experience at a tertiary hospital[J].ORPHANET JOURNAL of RARE DISEASES.2022,17(1):doi:10.1186/s13023-022-02271-3.
APA:
Liu Yi,Chen Zhehui,Dong Hui,Ding Yuan,He Ruxuan...&Yang Yanling.(2022).Analysis of the relationship between phenotypes and genotypes in 60 Chinese patients with propionic acidemia: a fourteen-year experience at a tertiary hospital.ORPHANET JOURNAL of RARE DISEASES,17,(1)
MLA:
Liu Yi,et al."Analysis of the relationship between phenotypes and genotypes in 60 Chinese patients with propionic acidemia: a fourteen-year experience at a tertiary hospital".ORPHANET JOURNAL of RARE DISEASES 17..1(2022)